- Home
- CRNX vs DAVE Comparison
CRNX vs DAVE Comparison
Compare CRNX & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- DAVE
- Stock Information
- Founded
- CRNX 2008
- DAVE 2017
- Country
- CRNX United States
- DAVE United States
- Employees
- CRNX N/A
- DAVE N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- DAVE Retail: Computer Software & Peripheral Equipment
- Sector
- CRNX Health Care
- DAVE Technology
- Exchange
- CRNX Nasdaq
- DAVE Nasdaq
- Market Cap
- CRNX 2.8B
- DAVE 3.2B
- IPO Year
- CRNX 2018
- DAVE N/A
- Fundamental
- Price
- CRNX $42.65
- DAVE $203.03
- Analyst Decision
- CRNX Buy
- DAVE Strong Buy
- Analyst Count
- CRNX 12
- DAVE 6
- Target Price
- CRNX $74.45
- DAVE $265.50
- AVG Volume (30 Days)
- CRNX 1.9M
- DAVE 411.5K
- Earning Date
- CRNX 11-11-2025
- DAVE 11-11-2025
- Dividend Yield
- CRNX N/A
- DAVE N/A
- EPS Growth
- CRNX N/A
- DAVE 70.95
- EPS
- CRNX N/A
- DAVE 3.84
- Revenue
- CRNX $1,392,000.00
- DAVE $433,065,000.00
- Revenue This Year
- CRNX $469.59
- DAVE $48.07
- Revenue Next Year
- CRNX $705.27
- DAVE $15.28
- P/E Ratio
- CRNX N/A
- DAVE $52.79
- Revenue Growth
- CRNX 0.51
- DAVE 47.97
- 52 Week Low
- CRNX $24.10
- DAVE $37.44
- 52 Week High
- CRNX $62.53
- DAVE $286.45
- Technical
- Relative Strength Index (RSI)
- CRNX 65.23
- DAVE 44.12
- Support Level
- CRNX $40.33
- DAVE $195.74
- Resistance Level
- CRNX $47.41
- DAVE $245.24
- Average True Range (ATR)
- CRNX 2.24
- DAVE 12.38
- MACD
- CRNX 0.31
- DAVE -2.78
- Stochastic Oscillator
- CRNX 65.12
- DAVE 16.40
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.